Study of advanced retinal degeneration natural history
Part of Eyes & vision, Genetic & congenital clinical trials.
This study follows people with advanced retinal degeneration (RCD) to learn how the disease progresses over time. It does not test a new treatment, but the information may help design future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a clinical diagnosis of advanced retinal degeneration due to RCD
- Your best corrected vision in at least one eye is 20/200 or worse
- You have some preserved retinal cells (foveal outer nuclear layer) in at least one eye
- You have a history of having formed vision at some point
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new gene therapy for people with advanced rod-cone dystrophy, a genetic condition that causes progressive vision loss. The treatment is given as an injection into the eye, and the study aims to see if it is safe and if it can help improve or preserve vision.
This study follows people with inherited retinal diseases to learn how these conditions progress and how genetic changes relate to symptoms. It may help improve future care and treatments.
This study measures how your eyes use two types of light-sensing cells (rods for dim light and cones for clearer detail). It may help researchers better understand retinal (retina) diseases and how well vision is functioning.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
This study looks at eye tissue from people with advanced diabetic retinopathy to understand why the disease gets so severe. It aims to find new ways to treat or prevent blindness in the future. You would be contributing tissue from a surgery you're already having.
Hear when a new Rod Cone Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.